Skip navigation

Leverage PBM Exclusions to Lower Costs and Explore Therapeutic Alternatives

March 30-31, 2016
  • Las Vegas, NV

In order to have strong competitive positioning and successful response to high cost drugs coming to the market, CBI’s PBM Formulary Exclusions Summit will provide you strategies to remain at the forefront of this highly competitive space. Drugs continue to be added to the formulary exclusion list each year, which is why, now more than ever, is the time to determine the primary drivers for formulary decision-making to enhance strategies that leverage these lists.

Benchmark Against Leading Experts to Remain at the Forefront of this Highly-Competitive Space:

  • Gain a deeper understanding on how PBM formulary exclusion lists work and what drives product exclusions and recommended alternatives
  • Hear how Premera Blue Cross developed a formulary based directly on value thresholds
  • Learn where restrictions provide the most value to the patient and the payer
  • Review the impact of relaxed approval criteria on plan cost, rebate guarantees and PBM profitability
  • Measure the impact of the rising costs of generic drugs on formulary management
  • Compare various formulary exclusion models that have been successfully implemented
  • Assess how to navigate complex rebate negotiations
  • Leverage the PBM exclusion list to improve outcomes and lower costs
  • Optimize coding for commercial and Medicaid formularies to be as precise and efficient as possible
  • Explore trends in specialty tier formularies and biosimilars

March 30-31, 2016 | Tropicana | Las Vegas, NV

PBM Formulary Exclusions Summit

Leverage PBM Exclusions to Lower Costs and Explore Therapeutic Alternatives

In order to have strong competitive positioning and successful response to high cost drugs coming to the market, CBI’s PBM Formulary Exclusions Summit will provide you strategies to remain at the forefront of this highly competitive space. Drugs continue to be added to the formulary exclusion list each year, which is why, now more than ever, is the time to determine the primary drivers for formulary decision-making to enhance strategies that leverage these lists.

Benchmark Against Leading Experts to Remain at the Forefront of this Highly-Competitive Space:

  • Gain a deeper understanding on how PBM formulary exclusion lists work and what drives product exclusions and recommended alternatives
  • Hear how Premera Blue Cross developed a formulary based directly on value thresholds
  • Learn where restrictions provide the most value to the patient and the payer
  • Review the impact of relaxed approval criteria on plan cost, rebate guarantees and PBM profitability
  • Measure the impact of the rising costs of generic drugs on formulary management
  • Compare various formulary exclusion models that have been successfully implemented
  • Assess how to navigate complex rebate negotiations
  • Leverage the PBM exclusion list to improve outcomes and lower costs
  • Optimize coding for commercial and Medicaid formularies to be as precise and efficient as possible
  • Explore trends in specialty tier formularies and biosimilars

March 30-31, 2016 | Tropicana | Las Vegas, NV